✦ LIBER ✦
The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma
✍ Scribed by D. S. Ritchie; J. F. Seymour; A. P. Grigg; A. W. Roberts; R. Hoyt; S. Thompson; J. Szer; H. M. Prince
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 113 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.